BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Applied Nanoscience Expands Technical Personnel to Begin Production of NanoFense(TM) Formulation


8/25/2009 10:22:19 AM

CARLSBAD, CA--(Marketwire - August 25, 2009) -

Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, today confirmed an expansion of its technical staff by adding three key positions to ensure a successful production scale-up and supply of the company's proprietary antimicrobial NanoFense™ technology, a U.S. patent pending nanoparticle formulation.

ANI recently announced a joint venture agreement with an Asia Pacific region partner to begin production of the NanoFense Protective Face Mask for launch to non-U.S. markets. Initial production will be 30,000 masks/day with the capability of increasing up to 90,000 masks/day on newly installed automatic equipment which operates 7 days a week. ANI will supply the NanoFense formulation premixed under their label.

"We are extremely fortunate to add a world class nano-silver expert along with two dedicated personnel for this critical component of our joint venture product launch. The importance of the pilot plant design and reliable daily production requirements cannot be overstated. We have accomplished this with the dedicated commitment of a very talented team and will be positioned to consistently supply enough formulation to 'coat' approximately 120,000 disposable NanoFense Protective Face Masks/day should the demand require. A 7-day production week equates to roughly 3.5 million masks per month," stated Thomas K. Allen, President and CEO, ANI.

The disposable NanoFense Protective Face Mask will be sold in many of the countries where ANI has issued patents protecting their broad NEFT™ platform. The patent coverage includes three main methods of associating nanoparticles with filter media: (1) coating the filter media with a powder of nanoparticles, (2) impregnating the nanoparticles into the filter media, and (3) having pellets of nanoparticles located adjacent to the filter media.

About ANI

ANI is a marketer and developer of innovative nanotechnology-based air filtration products specifically targeted to eradicate bacteria, virus and fungi and is the owner of NEFT (Nanoparticle - Enhanced - Filtration - Technology), a growing IP platform with which combines any type of nanoparticle that is known or engineered to be capable of destroying viruses, bacteria, fungi or toxins with one or more hydrophobic or hydrophilic filters. The Company is focused on both consumer and industrial market segments geared to reducing the transmission of infectious pathogens.

Safe Harbor Statement

This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. ANI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the company could differ significantly from such forward-looking statements.


For further information, please contact:
Thomas K. Allen
President and CEO
Applied Nanoscience Inc.
1902 Wright Place Suite 200
Carlsbad CA 92008
760-434-2400
or visit: www.appliednanoscience.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES